Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
VanEck Oil Services ETF
OIH
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Harvard Bioscience (HBIO)
- 6.360
- -0.020-0.31%
Close May 1 15:59 ET
- 6.360
- 0.0000.00%
Post 16:10 ET
28.68MMarket Cap-0.50P/E (TTM)
6.500High6.049Low19.01KVolume6.380Open6.380Prev Close118.02KTurnover0.54%Turnover RatioLossP/E (Static)4.51MShares9.45852wk High2.09P/B22.40MFloat Cap2.81352wk Low--Dividend TTM3.52MShs Float439.441Historical High--Div Yield TTM7.07%Range %2.813Historical Low6.209Avg Price1Lot Size
Harvard Bioscience (HBIO) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 367.29%6.73M | -105.57%-96K | 228.74%1.08M | 425.65%2.76M | 112.83%2.99M | -89.73%1.44M | -59.91%1.73M | -119.31%-842K | -123.82%-846K | -22.57%1.4M |
| Net income from continuing operations | -357.07%-56.7M | -15,916.67%-2.85M | 74.36%-1.23M | 22.04%-2.28M | -972.43%-50.34M | -263.25%-12.41M | 100.99%18K | -287.57%-4.8M | -198.67%-2.93M | -854.66%-4.69M |
| Operating gains losses | -14.44%1.36M | ---- | ---- | ---- | ---- | 595.63%1.59M | -579.92%-1.24M | ---- | ---- | 425.56%1.31M |
| Depreciation and amortization | -16.93%5.95M | -23.30%1.35M | -27.05%1.32M | -10.27%1.62M | -7.07%1.66M | 2.27%7.16M | -0.96%1.76M | 2.02%1.82M | 4.65%1.8M | 3.49%1.78M |
| Deferred tax | -287.33%-680K | -117.54%-127K | 102.60%20K | -121.83%-50K | -393.82%-523K | 8.04%363K | 196.72%724K | -12,900.00%-768K | 62.41%229K | 423.64%178K |
| Other non cash items | 304.28%1.32M | 536.73%624K | 301.12%357K | 200.00%210K | 87.14%131K | 16.79%327K | 40.00%98K | 27.14%89K | 0.00%70K | 0.00%70K |
| Change In working capital | 8,627.69%5.67M | -54.81%-918K | -45.08%290K | 276.74%2.79M | 105.62%3.51M | -98.59%65K | -124.82%-593K | -85.29%528K | -1,801.20%-1.58M | 231.79%1.71M |
| -Change in receivables | -195.89%-934K | -69.86%-3.96M | -35.48%-210K | -34.86%1.79M | 104.26%1.44M | 20.25%974K | -147.50%-2.33M | -108.52%-155K | 222.11%2.75M | 176.27%704K |
| -Change in inventory | 4,704.69%2.95M | -71.81%663K | 195.36%637K | 186.38%977K | 208.59%670K | -104.20%-64K | 74.09%2.35M | -196.89%-668K | -263.91%-1.13M | -111.30%-617K |
| -Change in payables and accrued expense | 228.85%2.3M | 153.06%797K | -1,835.71%-271K | 113.08%302K | -27.81%1.47M | -241.30%-1.79M | -567.56%-1.5M | 50.00%-14K | -1,823.33%-2.31M | 1,459.33%2.04M |
| -Change in other current assets | -7.37%1.52M | 43.04%1.1M | -78.17%368K | 104.66%24K | 109.73%29K | -0.55%1.64M | -54.79%769K | 38.42%1.69M | 46.35%-515K | 3.25%-298K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 96.43%-9K | -18.13%-430K |
| -Change in other working capital | 77.07%-161K | 308.55%478K | 27.10%-234K | 18.52%-308K | 19.17%-97K | -161.69%-702K | -76.74%117K | -268.95%-321K | -27.70%-378K | -116.19%-120K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 367.29%6.73M | -105.57%-96K | 228.74%1.08M | 425.65%2.76M | 112.83%2.99M | -89.73%1.44M | -59.91%1.73M | -119.31%-842K | -123.82%-846K | -22.57%1.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -38.62%-1.86M | -28.54%-599K | 68.68%-348K | -150.87%-233K | -203.56%-683K | 25.29%-1.34M | 56.08%-466K | -177.06%-1.11M | 173.28%458K | -178.13%-225K |
| Capital expenditure reported | 2.26%-605K | 9.09%-150K | 38.96%-141K | 2.70%-144K | -126.67%-170K | -18.36%-619K | 28.57%-165K | -25.54%-231K | -37.04%-148K | ---75K |
| Net PPE purchase and sale | 52.42%-1.26M | -49.17%-449K | 76.48%-207K | 89.12%-89K | 20.47%-513K | -47.87%-2.64M | 63.73%-301K | -305.53%-880K | -58.22%-818K | -187.95%-645K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | --1.92M | --0 | --0 | --1.42M | --495K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -38.62%-1.86M | -28.54%-599K | 68.68%-348K | -150.87%-233K | -203.56%-683K | 25.29%-1.34M | 56.08%-466K | -177.06%-1.11M | 173.28%458K | -178.13%-225K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -885.50%-1.29M | 280.47%2.45M | -160.74%-1.28M | -810.73%-1.26M | -14.12%-1.2M | 98.92%-131K | 67.03%-1.36M | 176.51%2.1M | 107.45%177K | 63.53%-1.06M |
| Net issuance payments of debt | 1,067.40%2.65M | 665.00%5.65M | -144.44%-1M | ---1M | 2.25%-1M | 102.15%227K | 55.56%-1M | 181.82%2.25M | --0 | 63.99%-1.02M |
| Proceeds from stock option exercised by employees | -87.63%47K | -99.38%1K | --0 | -75.66%46K | --0 | -59.14%380K | -21.84%161K | --15K | -69.52%189K | -85.58%15K |
| Net other financing activities | -440.38%-3.99M | -518.15%-3.2M | -72.67%-278K | -2,433.33%-304K | -334.04%-204K | 70.75%-738K | 75.00%-518K | ---161K | 95.93%-12K | 69.87%-47K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -885.50%-1.29M | 280.47%2.45M | -160.74%-1.28M | -810.73%-1.26M | -14.12%-1.2M | 98.92%-131K | 67.03%-1.36M | 176.51%2.1M | 107.45%177K | 63.53%-1.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -4.09%4.11M | 49.20%6.82M | 83.84%7.44M | 30.34%5.55M | -4.09%4.11M | -4.99%4.28M | -14.44%4.57M | -6.38%4.05M | 12.30%4.26M | -4.99%4.28M |
| Current changes in cash | 10,314.29%3.58M | 1,889.80%1.75M | -458.94%-542K | 699.05%1.26M | 793.50%1.1M | -136.84%-35K | 88.79%-98K | -87.52%151K | -138.22%-211K | 115.51%123K |
| Effect of exchange rate changes | 765.00%931K | 111.85%43K | -122.43%-83K | 15,700.00%632K | 324.50%339K | 56.25%-140K | -98.36%-363K | 290.72%370K | 123.53%4K | -304.05%-151K |
| End cash Position | 109.69%8.61M | 109.69%8.61M | 49.20%6.82M | 83.84%7.44M | 30.34%5.55M | -4.09%4.11M | -4.09%4.11M | -14.44%4.57M | -6.38%4.05M | 12.30%4.26M |
| Free cash flow | 366.92%4.87M | -155.20%-695K | 137.69%736K | 239.18%2.52M | 237.19%2.3M | -115.56%-1.82M | -61.17%1.26M | -149.32%-1.95M | -161.91%-1.81M | -56.99%683K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm